NCT04306211View on ClinicalTrials.gov

Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS

NATerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Endoscopic Ultrasound
Interventions
DEVICE

SuperNO2VA

SUPERNO2VA is nasal PAP device for oxygen delivery

Trial Locations (2)

46202-5121

Indiana University Health University Hospital, Indianapolis

Indiana University Hospital, Indianapolis

Sponsors

Collaborators (1)

Vyaire Medical
All Listed Sponsors
collaborator

Vyaire Medical

INDUSTRY

lead

Indiana University

OTHER

NCT04306211 - Comparison of Oxygenation Between Nasal PAP vs Nasal During Propofol-based Sedation for EUS | Biotech Hunter | Biotech Hunter